North America Remote Patient Monitoring And Care Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2030 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
USD 13,029.84 |
 CAGR |
% |
| Major Markets Players |
>北美远程病人监测和护理市场，按设备类型（心脏监测设备、血压监测设备、血糖监测设备、呼吸监测设备、神经监测设备、多参数监测设备等）、应用（肿瘤学、糖尿病、心血管疾病等）、最终用户（住院病人、门诊病人和家庭医疗保健患者）划分 - 行业趋势和预测到 2030 年。
北美远程病人监控和护理市场分析和洞察
近年来，远程医疗和护理在医疗保健服务中的应用越来越受欢迎，尤其是由于 COVID-19 疫情，远程医疗和护理方法导致对远程护理选项的需求增加。全球对远程医疗和护理的认识不断提高，增强了市场需求。为获得更好的医疗服务而增加的医疗支出也促进了市场增长。在这一关键时期，主要市场参与者专注于各种服务的推出和批准。此外，设备技术进步的提高也促进了对远程医疗和护理的需求增加。
由于市场参与者的增加和先进远程监控设备的普及，北美远程患者监控和护理市场预计将在预测年内增长。与此同时，制造商正致力于开发新设备和高效、准确的远程监控产品。先进医疗技术领域的不断发展进一步推动了市场的增长。然而，诸如对远程监控和护理产品的生产和商业化的严格规定等困难预计将在预测期内抑制市场增长。
医疗保健在进步和开发方面的支出增加预计将为市场增长提供机会。然而，远程监控和护理设备的高成本预计将对市场增长构成挑战。
各公司都在采取举措，逐步推动市场增长。
例如，
- 2023 年 1 月，CoachCare 宣布收购位于温斯顿塞勒姆的 RPM 公司 NVOLVE，以扩展其在疼痛、脊柱和骨科领域的 RPM 专业知识。此次收购将有助于该公司的产品组合和业务扩展。
Data Bridge Market Research分析，北美远程病人监控和护理市场预计到2030年将达到130.2984亿美元的价值，在2023-2030年的预测期内复合年增长率为13.1%。
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史性的一年 |
2021（可定制为 2015 – 2020） |
|
定量单位 |
收入（百万美元） |
|
涵盖的领域 |
设备类型（心脏监测设备、血压监测设备、血糖监测设备、呼吸监测设备、神经监测设备、多参数监测设备等）、应用（肿瘤科、糖尿病、心血管疾病等）、最终用户（住院患者、门诊患者和家庭医疗保健患者） |
|
覆盖国家 |
美国、加拿大和墨西哥 |
|
涵盖的市场参与者 |
美敦力、波士顿科学公司、VitalConnect、Biobeat、通用电气、荷兰皇家飞利浦电子公司、欧姆龙公司、雅培、日本光电公司、Vivify Health, Inc.、Aerotel Medical Systems、BIOTRONIK SE & Co. KG、A&D Company, Limited、AliveCor, Inc.、Masimo、Dexcom, Inc.、Senseonics, Inc.、ResMed、100Plus.、ChroniSense Medical, Ltd.、Vitls、cardiomo、CoachCare、neteera 和 Withings 等 |
市场定义
远程患者监测 (RPM) 和护理是一种医疗保健服务模式，允许医疗保健提供者使用各种技术设备和通信工具远程监测患者，而无需面对面就诊。这种方法使医疗保健提供者能够远程提供护理并跟踪患者健康数据，通常是实时的。
RPM 通常涉及使用带有传感器的可穿戴设备和其他技术设备，这些设备可以跟踪患者的生命体征、服药依从性、身体活动和其他健康相关信息。然后，收集的数据将传送给医疗保健提供者，医疗保健提供者可以分析这些信息并采取适当的措施，例如调整药物剂量、提供生活方式改变指导或安排后续预约。
北美远程病人监控和护理市场动态
本节旨在了解市场驱动因素、机遇、限制因素和挑战。下文将详细讨论所有这些内容：
司机
- 慢性病患病率不断上升
市场不断扩大的原因有很多，包括慢性病的日益流行。慢性病是一种非传染性疾病，持续时间长，需要持续的医疗护理和管理。
根据世界卫生组织的数据，慢性病占全球死亡人数的近 70%，其中心血管疾病是主要原因。由于人口老龄化、久坐的生活方式、营养不良和环境因素等多种因素，慢性病的患病率正在上升。RPM 和护理可以帮助医疗保健提供者更高效、更有效地管理慢性病。
由于人们久坐不动的生活方式，高血压和糖尿病等生活方式相关疾病的患病率有所上升。因此，随着医疗保健数据与便携式设备的日益融合，慢性病患病率的上升预计将需要适当的健康管理，从而导致预测期内市场对 RPM 和护理的需求预计会增加。
克制
- 严格的监管框架
监管机构在确保远程患者监测技术符合安全和质量标准以及保护患者隐私方面发挥着关键作用。然而，法规合规性可能是许多公司进入该领域的一大障碍，可能会减缓远程患者监测技术的采用。
医疗器械法规对保障医疗器械行业人员的健康负有重大责任。法规要求制造商将质量体系（基于国际公认的质量体系标准）灌输到 III 类和 IV 类器械的设计过程中。它们还要求制造商将其纳入 II、III 和 IV 类器械的制造过程中。
除了对医疗器械的严格监管外，据报道，加拿大卫生部对医疗器械申请的决定并不及时。该决定涉及审查制造商提交的科学证据，以确保各种器械的有效性。
这表明，如此繁琐的程序促成了其他技术先进的设备的发展，因此对设备制造商提交批准文件提出了巨大的挑战。
所实施的法规将延迟仪器的供应和设备的长期审批。这一因素预计将成为市场增长的制约因素。
机会
-
市场参与者的战略举措
主要市场参与者采取的战略举措有助于远程患者监控产品和设备的技术进步和发展。他们正在采取产品发布、合作、合并和收购等举措，预计这将为市场增长创造更多机会。
医疗保健产品供应商有巨大的机会与新技术公司合作，以确保行业的持续增长、创造力和可行性。
为了发现和开发先进的远程监控设施，公司正在启动新的举措并与其他主要参与者合作，以提供更可靠的结果和服务。
市场上主要公司采取的这些战略举措，例如产品发布、批准、收购和合并，为各个地区的公司开辟了机会。这一战略使公司能够加强其在市场上的影响力。因此，预计战略举措将为市场增长提供机会。
挑战
- 缺乏熟练的专业人员
远程病人监控需要一系列具有专业知识和专业技能的专业人员，包括临床医生、技术人员和数据分析师。
临床医生负责远程监控患者的健康状况并解释远程患者监控设备收集的数据。
此外，技术人员负责安装、维护和排除远程患者监测设备的故障。数据分析师负责分析远程患者监测设备收集的数据并向医疗保健提供者提供见解。然而，目前缺乏具备必要技能和经验的数据分析师、临床医生和技术人员，无法从远程患者监测数据中提供有意义的见解。
缺乏熟练的专业人员也会限制 RPM 技术的采用，并限制其改善医疗结果的潜力。如果没有熟练的专业人员，医疗保健提供者可能难以解释患者数据并提供适当的干预措施，从而限制 RPM 在改善患者结果方面的有效性。因此，缺乏熟练的专业人员是预计会对市场增长构成挑战的一个重要因素。
最新动态
- 2023 年 1 月，Masimo 和飞利浦宣布扩大合作伙伴关系，通过 Masimo W1 高级健康追踪手表增强家庭远程医疗应用中的患者监测能力。此次合作的扩展将有助于该公司扩大远程患者监测产品组合。
- 2022 年 12 月，Masimo 宣布全面推出 Masimo W1 手表的补水指数 (Hi)。Masimo W1 是一款先进的健康追踪可穿戴设备，是医院脉搏血氧仪领域的领导者推出的第一款提供准确、连续脉搏血氧仪测量和有见地的健康数据的手表。此次产品升级将有助于公司的产品业务扩展。
北美远程病人监控和护理市场范围
北美远程患者监控和护理市场分为三个显著的细分市场，例如设备类型、应用和最终用户。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
设备类型
- 心脏监测设备
- 血压监测设备
- 血糖监测设备
- 呼吸监测设备
- 神经监测设备
- 多参数监测设备
- 其他的
根据设备类型，市场分为心脏监测设备、血压监测设备、血糖监测设备、呼吸监测设备、神经监测设备、多参数监测设备等。
应用
- 肿瘤学
- 糖尿病
- 心血管疾病
- 其他的
根据应用，市场分为肿瘤学、糖尿病、心血管疾病和其他疾病。
最终用户
- 住院患者
- 门诊病人
- 家庭医疗保健患者
根据最终用户，市场分为住院患者、门诊患者和家庭医疗患者。
北美远程病人监控和护理市场区域分析/见解
北美远程病人监控和护理市场分为三个显著的部分，即设备类型、应用和最终用户。
本市场报告涵盖的国家包括美国、加拿大和墨西哥。
由于远程病人监控和护理产品的技术进步，美国预计将主导北美远程病人监控和护理市场。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测各个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了区域品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战，以及销售渠道的影响。
竞争格局和北美远程病人监控和护理市场份额分析
北美远程患者监测和护理市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品批准、产品宽度和广度、应用主导地位以及产品类型生命线曲线。以上提供的数据点仅与公司对市场的关注有关。
北美远程病人监测和护理市场的一些主要市场参与者包括美敦力、波士顿科学公司、VitalConnect、Biobeat、通用电气、荷兰皇家飞利浦公司、欧姆龙公司、雅培、日本光电公司、Vivify Health, Inc.、Aerotel Medical Systems、BIOTRONIK SE & Co. KG、A&D Company, Limited、AliveCor, Inc.、Masimo、Dexcom, Inc.、Senseonics, Inc.、ResMed、100Plus.、ChroniSense Medical, Ltd.、Vitls、cardiomo、CoachCare、neteera 和 Withings 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 CARDIAC MONITORING DEVICES LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 VALUE CHAIN ANALYSIS:
4.3 COMPETITIVE ANALYSIS
4.4 BRAND ANALYSIS
4.5 ECOSYSTEM MAPS
4.6 TECHNOLOGICAL TRENDS
4.7 TOP WINNING STRATEGIES
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
5.1.2 GROWTH IN TECHNOLOGICAL ADVANCEMENTS
5.1.3 INCREASING DEMAND FOR REMOTE PATIENT MONITORING
5.1.4 INCREASING GOVERNMENT INITIATIVES
5.2 RESTRAINTS
5.2.1 STRICT REGULATORY FRAMEWORK
5.2.2 LACK OF STANDARDIZATION
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS
5.3.2 PROVIDES QUICK AND REAL TIME RESULTS
5.4 CHALLENGES
5.4.1 LACK OF SKILLED PROFESSIONALS
5.4.2 RISK TO PATIENT'S DATA SECURITY
6 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE
6.1 OVERVIEW
6.2 CARDIAC MONITORING DEVICES
6.3 BLOOD PRESSURE MONITORING DEVICES
6.4 MULTI-PARAMETER MONITORING DEVICES
6.5 BLOOD GLUCOSE MONITORING DEVICES
6.6 RESPIRATORY MONITORING DEVICES
6.7 NEUROLOGICAL MONITORING DEVICES
6.8 OTHERS
7 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 CARDIOVASCULAR DISEASE
7.2.1 CORONARY HEART DISEASE
7.2.2 STROKE
7.2.3 PERIPHERAL ARTERIAL DISEASE
7.2.4 AORTIC DISEASE
7.2.5 OTHERS
7.3 DIABETES
7.4 ONCOLOGY
7.5 OTHERS
8 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER
8.1 OVERVIEW
8.2 HOME HEALTHCARE PATIENTS
8.2.1 BLOOD GLUCOSE MONITORING DEVICES
8.2.2 CARDIAC MONITORING DEVICES
8.2.3 BLOOD PRESSURE MONITORING DEVICES
8.2.4 MULTI-PARAMETER MONITORING DEVICES
8.2.5 RESPIRATORY MONITORING DEVICES
8.2.6 NEUROLOGICAL MONITORING DEVICES
8.2.7 OTHERS
8.3 AMBULATORY PATIENTS
8.3.1 MULTI-PARAMETER MONITORING DEVICES
8.3.2 RESPIRATORY MONITORING DEVICES
8.3.3 CARDIAC MONITORING DEVICES
8.3.4 BLOOD PRESSURE MONITORING DEVICES
8.3.5 BLOOD GLUCOSE MONITORING DEVICES
8.3.6 NEUROLOGICAL MONITORING DEVICES
8.3.7 OTHERS
8.4 HOSPITAL-BASED PATIENTS
8.4.1 MULTI-PARAMETER MONITORING DEVICES
8.4.2 CARDIAC MONITORING DEVICES
8.4.3 RESPIRATORY MONITORING DEVICES
8.4.4 BLOOD PRESSURE MONITORING DEVICES
8.4.5 BLOOD GLUCOSE MONITORING DEVICES
8.4.6 NEUROLOGICAL MONITORING DEVICES
8.4.7 OTHERS
9 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION
9.1 NORTH AMERICA
9.1.1 U.S.
9.1.2 CANADA
9.1.3 MEXICO
10 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
11 SWOT ANALYSIS
12 COMPANY PROFILE
12.1 MEDTRONIC
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 DEXCOM, INC.
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 ABBOTT
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENT
12.4 RESMED
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENT
12.5 BIOTRONIK SE & CO. KG
12.5.1 COMPANY SNAPSHOT
12.5.2 COMPANY SHARE ANALYSIS
12.5.3 PRODUCT PORTFOLIO
12.5.4 RECENT DEVELOPMENT
12.6 100 PLUS.
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENTS
12.7 A&D COMPANY, LIMITED
12.7.1 COMPANY SNAPSHOT
12.7.2 REVENUE ANALYSIS
12.7.3 COMPANY SHARE ANALYSIS
12.7.4 PRODUCT PORTFOLIO
12.7.5 RECENT DEVELOPMENT
12.8 AEROTEL MEDICAL SYSTEMS
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENT
12.9 ALIVECOR, INC.
12.9.1 COMPANY SNAPSHOT
12.9.2 COMPANY SHARE ANALYSIS
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENTS
12.1 BIOBEAT
12.10.1 COMPANY SNAPSHOT
12.10.2 PRODUCT PORTFOLIO
12.10.3 RECENT DEVELOPMENT
12.11 BOSTON SCIENTIFIC CORPORATION
12.11.1 COMPANY SNAPSHOT
12.11.2 REVENUE ANALYSIS
12.11.3 COMPANY SHARE ANALYSIS
12.11.4 PRODUCT PORTFOLIO
12.11.5 RECENT DEVELOPMENT
12.12 CARDIOMO
12.12.1 COMPANY SNAPSHOT
12.12.2 PRODUCT PORTFOLIO
12.12.3 RECENT DEVELOPMENTS
12.13 CHRONISENSE MEDICAL, LTD.
12.13.1 COMPANY SNAPSHOT
12.13.2 PRODUCT PORTFOLIO
12.13.3 RECENT DEVELOPMENT
12.14 COACHCARE
12.14.1 COMPANY SNAPSHOT
12.14.2 PRODUCT PORTFOLIO
12.14.3 RECENT DEVELOPMENT
12.15 GENERAL ELECTRIC
12.15.1 COMPANY SNAPSHOT
12.15.2 REVENUE ANALYSIS
12.15.3 COMPANY SHARE ANALYSIS
12.15.4 PRODUCT PORTFOLIO
12.15.5 RECENT DEVELOPMENT
12.16 KONINKLIJKE PHILIPS N.V.
12.16.1 COMPANY SNAPSHOT
12.16.2 REVENUE ANALYSIS
12.16.3 COMPANY SHARE ANALYSIS
12.16.4 PRODUCT PORTFOLIO
12.16.5 RECENT DEVELOPMENT
12.17 MASIMO
12.17.1 COMPANY SNAPSHOT
12.17.2 REVENUE ANALYSIS
12.17.3 COMPANY SHARE ANALYSIS
12.17.4 PRODUCT PORTFOLIO
12.17.5 RECENT DEVELOPMENT
12.18 NETEERA
12.18.1 COMPANY SNAPSHOT
12.18.2 PRODUCT PORTFOLIO
12.18.3 RECENT DEVELOPMENT
12.19 NIHON KOHDEN CORPORATION
12.19.1 COMPANY SNAPSHOT
12.19.2 REVENUE ANALYSIS
12.19.3 COMPANY SHARE ANALYSIS
12.19.4 PRODUCT PORTFOLIO
12.19.5 RECENT DEVELOPMENT
12.2 OMRON CORPORATION
12.20.1 COMPANY SNAPSHOT
12.20.2 REVENUE ANALYSIS
12.20.3 COMPANY SHARE ANALYSIS
12.20.4 PRODUCT PORTFOLIO
12.20.5 RECENT DEVELOPMENT
12.21 SENSEONICS, INC.
12.21.1 COMPANY SNAPSHOT
12.21.2 REVENUE ANALYSIS
12.21.3 COMPANY SHARE ANALYSIS
12.21.4 PRODUCT PORTFOLIO
12.21.5 RECENT DEVELOPMENT
12.22 VITALCONNECT
12.22.1 COMPANY SNAPSHOT
12.22.2 PRODUCT PORTFOLIO
12.22.3 RECENT DEVELOPMENT
12.23 VITLS
12.23.1 COMPANY SNAPSHOT
12.23.2 PRODUCT PORTFOLIO
12.23.3 RECENT DEVELOPMENT
12.24 VIVIFY HEALTH INC.
12.24.1 COMPANY SNAPSHOT
12.24.2 PRODUCT PORTFOLIO
12.24.3 RECENT DEVELOPMENTS
12.25 WITHINGS
12.25.1 COMPANY SNAPSHOT
12.25.2 COMPANY SHARE ANALYSIS
12.25.3 PRODUCT PORTFOLIO
12.25.4 RECENT DEVELOPMENT
13 QUESTIONNAIRE
14 RELATED REPORTS
表格列表
TABLE 1 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 2 NORTH AMERICA CARDIAC MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 NORTH AMERICA BLOOD PRESSURE MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 4 NORTH AMERICA MULTI-PARAMETER MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 NORTH AMERICA BLOOD GLUCOSE MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 NORTH AMERICA RESPIRATORY MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 7 NORTH AMERICA NEUROLOGICAL MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 8 NORTH AMERICA OTHERS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 10 NORTH AMERICA CARDIOVASCULAR DISEASE IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 11 NORTH AMERICA CARDIOVASCULAR DISEASE IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 12 NORTH AMERICA DIABETES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 13 NORTH AMERICA ONCOLOGY IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 NORTH AMERICA OTHERS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 16 NORTH AMERICA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 NORTH AMERICA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 18 NORTH AMERICA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 NORTH AMERICA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 20 NORTH AMERICA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 NORTH AMERICA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 22 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 24 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 27 NORTH AMERICA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 28 NORTH AMERICA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 29 NORTH AMERICA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 30 U.S. REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 31 U.S. REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 32 U.S. CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 33 U.S. REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 34 U.S. HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 35 U.S. AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 36 U.S. HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 37 CANADA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 38 CANADA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 39 CANADA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 40 CANADA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 41 CANADA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 42 CANADA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 43 CANADA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 44 MEXICO REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 45 MEXICO REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 46 MEXICO CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 47 MEXICO REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 48 MEXICO HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 49 MEXICO AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 50 MEXICO HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
图片列表
FIGURE 1 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: SEGMENTATION
FIGURE 11 THE INCREASING PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE GROWTH OF THE NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET IN THE FORECAST PERIOD
FIGURE 12 THE CARDIAC MONITORING DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET IN 2023 AND 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET
FIGURE 14 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, 2022
FIGURE 15 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, 2023-2030 (USD MILLION)
FIGURE 16 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, CAGR (2023-2030)
FIGURE 17 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, LIFELINE CURVE
FIGURE 18 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, 2022
FIGURE 19 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 20 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 21 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 22 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, 2022
FIGURE 23 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 24 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 25 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, LIFELINE CURVE
FIGURE 26 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: SNAPSHOT (2022)
FIGURE 27 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022)
FIGURE 28 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2023 & 2030)
FIGURE 29 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022 & 2030)
FIGURE 30 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: DEVICE TYPE (2023-2030)
FIGURE 31 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: COMPANY SHARE 2022 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
